Clene Inc. (NASDAQ: CLNN) is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. The company is known for its pioneering work in nanotherapeutics, which involves using nanotechnology to create new medical treatments. Clene's competitors include other biotech firms working on similar therapies, such as Biogen and Novartis.On January 7, 2026, Ugwumba Chidozie, a significant shareholder of CLNN, sold 3,938 shares at $6.29 each. This transaction is part of a serie ...